Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice

BACKGROUND: Although cisplatin is one of the most effective chemotherapeutic agents, cisplatin alone does not achieve a satisfactory therapeutic outcome. Also cisplatin accumulation shows toxicity to normal tissues. In this study, we examined the possibility of HemoHIM both to enhance anticancer eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hae-Ran, Ju, Eun-Jin, Jo, Sung-Kee, Jung, Uhee, Kim, Sung-Ho, Yee, Sung-Tae
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666758/
https://www.ncbi.nlm.nih.gov/pubmed/19292900
http://dx.doi.org/10.1186/1471-2407-9-85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666758/
https://www.ncbi.nlm.nih.gov/pubmed/19292900
http://dx.doi.org/10.1186/1471-2407-9-85

Ejemplares similares